Related Experiment Video
Updated: Jun 4, 2026
A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
[Animal models for bone and joint disease. Bone disease of osteoprotegerin deficient mouse]
Tomoka Hasegawa1, Muneteru Sasaki, Chihiro Tabata
1Department of Developmental Biology of Hard Tissue, Graduate School of Dental Medicine, Hokkaido University.
Abstract:
Osteoprotegerin (OPG) acts as a decoy receptor for the receptor activator of the nuclear factor κ B (RANK) ligand (RANKL) , preventing its association with RANK and inhibiting osteoclastogenesis. Therefore, mice homozygous for targeted disruption of the OPG gene reveal stimulated bone resorption and bone formation, resulting in enhanced bone remodeling. The OPG deficient (OPG( - / - )) mouse showed the diturbed distribution of collagen fibers and complex meshwork of cement lines, which implies weakened strength of OPG( - / - ) bone against mechanical stress. In addition, the abnormally promoted remodeling of the OPG( - / - ) bone caused the disorganized distribution of osteocyte lacunar canalicular system (OLCS) . Histochemical assessment revealed the markedly reduced synthesis of sclerostin in the OPG( - / - ) OLCS while the synthesis of dentin matrix protein-1 was not extremely affected by the OPG deficiency. Taken together, OPG deficient mouse appears to be a valid model for extremely-stimulated bone remodeling, and would provided important clues for better understanding for activities of bone cells in a pathological state in bone.
Insights
Osteoprotegerin (OPG) deficiency in mice leads to accelerated bone remodeling, weakening bones and disrupting cellular structures. This OPG-deficient model offers insights into pathological bone conditions.
Area of Science:
- Bone Biology
- Skeletal Physiology
- Pathological Bone Remodeling
Background:
- Osteoprotegerin (OPG) is a crucial regulator of bone remodeling.
- OPG functions as a decoy receptor for RANKL, inhibiting osteoclastogenesis.
- OPG deficiency results in dysregulated bone turnover.
Purpose of the Study:
- To investigate the skeletal characteristics of OPG-deficient mice.
- To evaluate the impact of OPG deficiency on bone microarchitecture and cellular organization.
- To establish OPG-deficient mice as a model for studying extreme bone remodeling.
Main Methods:
- Genetic disruption of the OPG gene in mice (OPG-/-).
- Analysis of bone collagen fiber distribution and cement lines.
- Assessment of the osteocyte lacunar canalicular system (OLCS).
- Histochemical analysis of sclerostin and dentin matrix protein-1 synthesis.
Main Results:
- OPG-/- mice exhibit stimulated bone resorption and formation, leading to enhanced bone remodeling.
- Disturbed collagen fiber distribution and complex cement lines indicate weakened bone strength.
- Disorganized OLCS and reduced sclerostin synthesis observed in OPG-/- bone.
- Dentin matrix protein-1 synthesis was not significantly affected by OPG deficiency.
Conclusions:
- OPG-deficient mice serve as a valid model for studying extremely stimulated bone remodeling.
- Findings provide insights into the cellular activities and mechanical properties of bone in pathological states.
- Understanding OPG's role is critical for developing therapeutic strategies for bone diseases.
